Dianthus Therapeutics, Inc. (DNTH): Cash & Equivalents
$51.09M
As of 2025-12-31
$110.55M
As of 2026-06-30
+49.3%
3-year compound annual growth
-2.6%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $51.09M | +124.1% | 2026-03-09, Balance as of period end |
| 2024-12-31 | $22.79M | -82.8% | 2026-03-09, Balance as of period end |
| 2023-12-31 | $132.32M | +761.2% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $15.37M | -88.3% | 2024-03-21, Balance as of period end |
| 2021-12-31 | $131.65M | +126.4% | 2023-03-23, Balance as of period end |
| 2020-12-31 | $58.15M | -10.6% | 2022-03-08, Balance as of period end |
| 2019-12-31 | $65.07M | +11.5% | 2021-03-03, Balance as of period end |
| 2018-12-31 | $58.34M | +13.5% | 2020-03-03, Balance as of period end |
| 2017-12-31 | $51.40M | n/a | 2019-03-19, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Dianthus Therapeutics, Inc. (DNTH) | 2025-12-31 | $51.09M | +124.1% |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $3.24M | +0.2% |
| Lipocine Inc. (LPCN) | 2025-12-31 | $5.21M | -16.1% |
| Bio Essence Corp (BIOE) | 2024-12-31 | $1.4K | n/m |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $3.09M | -44.0% |
| Rani Therapeutics Holdings, Inc. (RANI) | 2025-12-31 | $18.62M | +394.9% |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | $125.14M | -41.1% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $101.58M | -68.8% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | $7.80M | +440.3% |
Compare DNTH, KRSA, LPCN, BIOE side by side · Screen every company in Pharmaceutical Preparations ↗